METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours (2022)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.3332/ecancer.2022.1369
- Subjects: NEUROENDOCRINOLOGIA; CARCINOMA NEUROENDÓCRINO; NEOPLASIAS; METFORMINA
- Language: Inglês
- Imprenta:
- Source:
- Título: Ecancermedicalscience
- ISSN: 1754-6605
- Volume/Número/Paginação/Ano: v. 16, article ID 1369, 14p, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GLASBERG, Joao et al. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. Ecancermedicalscience, v. 16, 2022Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2022.1369. Acesso em: 09 jan. 2026. -
APA
Glasberg, J., Talans, A., Giollo, T. R., Recchimuzzi, D. Z., Bezerra Neto, J. E., López, R. V. M., et al. (2022). METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours. Ecancermedicalscience, 16. doi:10.3332/ecancer.2022.1369 -
NLM
Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Bezerra Neto JE, López RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours [Internet]. Ecancermedicalscience. 2022 ; 16[citado 2026 jan. 09 ] Available from: https://doi.org/10.3332/ecancer.2022.1369 -
Vancouver
Glasberg J, Talans A, Giollo TR, Recchimuzzi DZ, Bezerra Neto JE, López RVM, Hoff PMG, Riechelmann RP. METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours [Internet]. Ecancermedicalscience. 2022 ; 16[citado 2026 jan. 09 ] Available from: https://doi.org/10.3332/ecancer.2022.1369 - Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community
- Immune-mediated pancytopenia induced by oxaliplatin: a case report
- A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
- Palliative chemotherapy in patients with malignant bowel obstruction
- Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
- Is surgery always necessary in rectal cancer?
- Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database
- Pneumonite induzida por taxanos: relato de três casos e revisão da literatura
- O câncer no envelhecimento
- "É fundamental ter compaixão ao tratar um paciente com câncer" [Entrevista]
Informações sobre o DOI: 10.3332/ecancer.2022.1369 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
